UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

Circulation (New York, N.Y.), 2004-06, Vol.109 (21 Suppl 1), p.II18-II26

2004

Volltextzugriff (PDF)

CD40 Signaling and Plaque Instability

Circulation research, 2001-12, Vol.89 (12), p.1092-1103

2001

Volltextzugriff (PDF)

Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Circulation research, 2002-08, Vol.91 (4), p.281-291

2002

Volltextzugriff (PDF)

Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells

Arteriosclerosis, thrombosis, and vascular biology, 2006-03, Vol.26 (3), p.611-617

2006

Volltextzugriff (PDF)

Family History of Diabetes Is a Major Determinant of Endothelial Function

Journal of the American College of Cardiology, 2006-06, Vol.47 (12), p.2456-2461

2006

Volltextzugriff (PDF)

Soluble CD40L and cardiovascular risk in women

Circulation (New York, N.Y.), 2001-11, Vol.104 (19), p.2266-2268

2001

Volltextzugriff (PDF)

CD40 ligand mediates inflammation independently of CD40 by interaction with mac-1

Circulation (New York, N.Y.), 2007-03, Vol.115 (12), p.1571-1580

2007

Volltextzugriff (PDF)

Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis

The Journal of immunology (1950), 2000-09, Vol.165 (6), p.3506-3518

2000

Volltextzugriff (PDF)

Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells

Circulation research, 1998-11, Vol.83 (11), p.1097-1103

1998

Volltextzugriff (PDF)

Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques

Circulation (New York, N.Y.), 1999-05, Vol.99 (19), p.2503-2509

1999

Volltextzugriff (PDF)

TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells

Arteriosclerosis, thrombosis, and vascular biology, 2007-05, Vol.27 (5), p.1101-1107

2007

Volltextzugriff (PDF)

Soluble CD40L: Risk prediction after acute coronary syndromes

Circulation (New York, N.Y.), 2003-09, Vol.108 (9), p.1049-1052

2003

Volltextzugriff (PDF)

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study

Arteriosclerosis, thrombosis, and vascular biology, 2007-09, Vol.27 (9), p.2043-2049

2007

Volltextzugriff (PDF)

Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions

The American journal of pathology, 1999-10, Vol.155 (4), p.1281-1291

1999

Volltextzugriff (PDF)

Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing

The Journal of immunology (1950), 1998-10, Vol.161 (7), p.3340-3346

1998

Volltextzugriff (PDF)

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

Circulation (New York, N.Y.), 2002-12, Vol.106 (23), p.2888-2893

2002

Volltextzugriff (PDF)

Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling

Circulation (New York, N.Y.), 2001-10, Vol.104 (16), p.1899-1904

2001

Volltextzugriff (PDF)

Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones

Circulation (New York, N.Y.), 2003-06, Vol.107 (21), p.2664-2669

2003

Volltextzugriff (PDF)

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Nature (London), 1998-07, Vol.394 (6689), p.200-203

1998

Volltextzugriff (PDF)

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

Proceedings of the National Academy of Sciences - PNAS, 1997-03, Vol.94 (5), p.1931-1936

1997

Volltextzugriff (PDF)

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40 : Induction of collagenase, stromelysin, and tissue factor

Circulation (New York, N.Y.), 1997-07, Vol.96 (2), p.396-399

1997

Volltextzugriff (PDF)

Cytokines in the pathogenesis of atherosclerosis

Thrombosis and haemostasis, 2002-10, Vol.88 (4), p.554-567

2002

Volltextzugriff (PDF)

Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells

Arteriosclerosis, thrombosis, and vascular biology, 2005-06, Vol.25 (6), p.1244-1249

2005

Volltextzugriff (PDF)

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study

Arteriosclerosis, thrombosis, and vascular biology, 2005-10, Vol.25 (10), p.2192-2196

2005

Volltextzugriff (PDF)

Influence of pre-analytical and analytical factors on soluble CD40L measurements

Clinical science (1979), 2006-11, Vol.111 (5), p.341-347

2006

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

Science & Technology
(50)
Life Sciences & Biomedicine
(48)
Humans
(42)
Atherosclerosis
(32)
Biological And Medical Sciences
(32)
Medical Sciences
(30)
Cardiovascular System & Cardiology
(29)
Peripheral Vascular Disease
(26)
Cardiology. Vascular System
(25)
Blood And Lymphatic Vessels
(23)
Cardiac & Cardiovascular Systems
(19)
Animals
(17)
Hematology
(16)
Inflammation
(16)
Cells, Cultured
(14)
Cd40 Ligand
(13)
Mice
(11)
Muscle, Smooth, Vascular - Metabolism
(11)
Cd40 Antigens - Metabolism
(10)
Cd40 Ligand - Blood
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents?

CD40 Signaling and Plaque Instability

Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Metformin Inhibits Proinflammatory Responses and Nuclear Factor-κB in Human Vascular Wall Cells

Family History of Diabetes Is a Major Determinant of Endothelial Function

Soluble CD40L and cardiovascular risk in women

CD40 ligand mediates inflammation independently of CD40 by interaction with mac-1

Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis

Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression and Migration in Human Vascular Smooth Muscle Cells

Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques

TRAF-1, -2, -3, -5, and -6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells

Soluble CD40L: Risk prediction after acute coronary syndromes

Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study

Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions

Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing

Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells

Expression of neutrophil collagenase (matrix metalloproteinase-8) in human atheroma: a novel collagenolytic pathway suggested by transcriptional profiling

Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: A novel target of thiazolidinediones

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40 : Induction of collagenase, stromelysin, and tissue factor

Cytokines in the pathogenesis of atherosclerosis

Atherogenesis in mice does not require CD40 ligand from bone marrow-derived cells

Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study

Influence of pre-analytical and analytical factors on soluble CD40L measurements

Suchergebnisse filtern